Masterarbeit, 2013
106 Seiten
1. Introduction
2. Drug Profile
3. Aims and Objectives
4. Plan of Work
5. Results and Discussion
6. Experimental
7. References
This work aims to address the challenges in the quality control of multi-component pharmaceutical formulations by developing and validating simple, accurate, and robust chromatographic methods, specifically utilizing High-Performance Thin-Layer Chromatography (HPTLC) and Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) in accordance with ICH Q2 (R1) guidelines.
Selection of mobile phase:
Aliquot portions of standard drug solutions were applied on silica gel TLC plates and used for selection of mobile phase. Based on the literature survey26 toluene: ethyl acetate: methanol: ammonia (2: 7: 3: 0.2, v/v/v/v) was used as initial mobile phase, but there was little movement of MOXI and no movement of DEXA Na P. After that, different ratios of same components were used but DEXA Na P was not moving at all. Formic acid and acetic acid were also tried by replacing ammonia in the above mentioned solvent system, but results showed a very broad peak for DEXA Na P. After that, different solvents with varying polarity as well as combination of solvents were tried based on the literature to get well resolved bands of the drugs. After trying several permutations and combinations, the solvent system containing dichloromethane: methanol: ammonia: acetonitrile in the ratio of (6: 5: 2.5: 5, v/v/v/v) was found to be most satisfactory as it gave good resolution for both the drugs. Hence, the same was used for all further studies of this combination of drugs.
Introduction: Provides a comprehensive overview of analytical chemistry, the classification of various analytical methods, and the fundamental principles of UV-Visible spectroscopy and chromatography.
Drug Profile: Presents detailed chemical structures, properties, and therapeutic categories for the pharmaceutical compounds investigated in this study.
Aims and Objectives: Outlines the necessity for new, validated analytical methods and defines the specific research goals regarding the simultaneous estimation of selected drug combinations.
Plan of Work: Details the systematic research strategy, including the selection of techniques and the procedural steps for method development and validation.
Results and Discussion: Discusses the optimization of chromatographic conditions, validation parameters such as linearity, precision, and accuracy, and the application of these methods to market samples.
Experimental: Describes the materials, instruments, software, and methodological procedures used to conduct the experimental research.
References: Lists the academic and technical sources utilized to support the methodology and findings of the research.
Analytical Chemistry, Chromatography, HPTLC, RP-HPLC, Method Validation, Simultaneous Estimation, Metformin, Pioglitazone, Gliclazide, Moxifloxacin, Dexamethasone, Ciprofloxacin, Quality Control, Pharmaceutical Formulations, ICH Guidelines
The research focuses on the development and validation of reliable, chromatographic analytical methods (HPTLC and HPLC) for the simultaneous estimation of various multi-component drug formulations to ensure quality control.
The central themes include the design of separation methods, optimization of chromatographic conditions, adherence to ICH guidelines for method validation, and the practical application of these methods to commercial pharmaceutical products.
The primary goal is to provide accurate, precise, and robust analytical procedures that allow for the efficient simultaneous analysis of multi-component drug combinations that are not currently well-addressed by existing pharmacopoeial methods.
The study primarily utilizes High-Performance Thin-Layer Chromatography (HPTLC) and Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC).
The main body covers the theoretical background of chromatography and spectroscopy, specific method development for three distinct drug combinations, comprehensive validation studies (linearity, precision, accuracy, specificity, robustness), and practical application to marketed eye drop and tablet formulations.
Validation is demonstrated through rigorous testing according to ICH Q2 (R1) guidelines, specifically measuring parameters like accuracy, precision (repeatability and intermediate precision), specificity, limit of detection, and limit of quantification.
HPTLC is highlighted for its advantages such as short development time, a wide choice of stationary phases, and the ability to visualize separated compounds, making it a powerful tool for complex pharmaceutical mixture analysis.
Suitability is determined by evaluating system suitability parameters such as resolution (Rs), capacity factor (k), selectivity factor (α), number of theoretical plates (N), and tailing factor (T).
Der GRIN Verlag hat sich seit 1998 auf die Veröffentlichung akademischer eBooks und Bücher spezialisiert. Der GRIN Verlag steht damit als erstes Unternehmen für User Generated Quality Content. Die Verlagsseiten GRIN.com, Hausarbeiten.de und Diplomarbeiten24 bieten für Hochschullehrer, Absolventen und Studenten die ideale Plattform, wissenschaftliche Texte wie Hausarbeiten, Referate, Bachelorarbeiten, Masterarbeiten, Diplomarbeiten, Dissertationen und wissenschaftliche Aufsätze einem breiten Publikum zu präsentieren.
Kostenfreie Veröffentlichung: Hausarbeit, Bachelorarbeit, Diplomarbeit, Dissertation, Masterarbeit, Interpretation oder Referat jetzt veröffentlichen!

